| __timestamp | BioCryst Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13608000 | 122045000 |
| Thursday, January 1, 2015 | 48257000 | 144427000 |
| Friday, January 1, 2016 | 26353000 | 215003000 |
| Sunday, January 1, 2017 | 25186000 | 302238000 |
| Monday, January 1, 2018 | 20653000 | 408897000 |
| Tuesday, January 1, 2019 | 48835000 | 392755000 |
| Wednesday, January 1, 2020 | 17812000 | 520397000 |
| Friday, January 1, 2021 | 157170000 | 579775000 |
| Saturday, January 1, 2022 | 270827000 | 667238000 |
| Sunday, January 1, 2023 | 331412000 | 607521000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, revenue growth is a key indicator of success. Over the past decade, Supernus Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc. have shown distinct trajectories. Supernus has consistently outperformed BioCryst, with revenues peaking at approximately $667 million in 2022, a remarkable 450% increase from 2014. In contrast, BioCryst's revenue, while growing, reached around $331 million in 2023, marking a substantial 2,300% increase from its 2014 figures. This stark difference highlights Supernus's robust market strategy and product portfolio, which have driven its steady ascent. Meanwhile, BioCryst's recent surge suggests a promising future, potentially fueled by innovative treatments and strategic partnerships. As the pharmaceutical industry evolves, these companies exemplify the dynamic nature of growth and competition, offering valuable insights into market trends and future opportunities.
Novo Nordisk A/S vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Sanofi or BioCryst Pharmaceuticals, Inc.?
Revenue Insights: Gilead Sciences, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Annual Revenue Comparison: Biogen Inc. vs BioCryst Pharmaceuticals, Inc.
Revenue Showdown: BeiGene, Ltd. vs Supernus Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs BioCryst Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Revenue Insights: Pharming Group N.V. and Supernus Pharmaceuticals, Inc. Performance Compared
Comparing Revenue Performance: TG Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Galapagos NV?
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Evotec SE?
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.